Fundraising Fox

Twist Bioscience

NASDAQ: TWST

South San Francisco, US · Founded 2013 · Delaware corporation · 13 known investors

twistbioscience.com ↗

Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.

BiotechDeep TechSemiconductorsin /twist-bioscience@TwistBioscience

Founders & leadership

KC
Keith CrandellDirector
PC
Paul ConleyDirector
FC
Fred CravesDirector
EM
Emily Marine LeproustExecutive Officer, Director, Promoter
WC
William Charles BanyaiExecutive Officer, Director, Promoter
BJ
Bill James PeckExecutive Officer, Promoter
RC
Rob ChessDirector

Investors · 13

+ND CapitalWoodside · $540K – $5.4M
3E Bioventures CapitalPalo Alto
ARCH Venture PartnersChicago · $50K – $250Mvia Keith Crandell · board
Asset Management CompanyMenlo Park · $500K – $2M
Bay City CapitalSan Rafael · $5M – $10M
Black Opal VenturesNew York
Dentsu VenturesTokyo
iGlobe PartnersSingapore · $600K – $6M
LionBirdTel Aviv · $200K – $500K
OMX VenturesLincolnshire
Paladin Capital GroupWashington · $100K – $5M
Prime PartnersTokyo
Vital Venture CapitalWashington · $1M – $3M

Reported raises · per SEC filings

Form D private placements
▶$50MraisedApr 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith CrandellDirector
  • Paul ConleyDirector
  • Bob RagusaDirector
  • Minqi LiDirector
  • Rob ChessDirector
  • William BanyaiExecutive Officer, Director
  • Fred CravesDirector
  • Bill PeckExecutive Officer
  • Emily Marine LeproustExecutive Officer, Director
Offering amount
$85M
Amount sold
$50M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$74.9MraisedDec 2017 · 63 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith CrandellDirector
  • Bill PeckExecutive Officer
  • Paul ConleyDirector
  • Emily Marine LeproustExecutive Officer, Director
  • Bob RagusaDirector
  • Rob ChessDirector
  • Fred CravesDirector
  • William BanyaiExecutive Officer, Director
Offering amount
$75M
Amount sold
$74.9M
First sale
Mar 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedApr 2016 · 46 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith CrandellDirector
  • William Charles BanyaiExecutive Officer, Director
  • Paul ConleyDirector
  • Solange GlaizeExecutive Officer
  • Rob ChessDirector
  • Fred CravesDirector
  • Bill James PeckExecutive Officer
  • Emily Marine LeproustExecutive Officer, Director
  • Nick NaclerioDirector
Offering amount
$2.6M
Amount sold
$2.6M
First sale
Apr 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$61MraisedJan 2016 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Emily Marine LeproustExecutive Officer, Director, Promoter
  • William Charles BanyaiExecutive Officer, Director, Promoter
  • Paul ConleyDirector
  • Nick NaclerioDirector
  • Rob ChessDirector
  • Keith CrandellDirector
  • Fred CravesDirector
  • Bill James PeckExecutive Officer, Promoter
Offering amount
$61M
Amount sold
$61M
First sale
Jan 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37MraisedJun 2015 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith CrandellDirector
  • Paul ConleyDirector
  • Fred CravesDirector
  • Emily Marine LeproustExecutive Officer, Director, Promoter
  • William Charles BanyaiExecutive Officer, Director, Promoter
  • Bill James PeckExecutive Officer, Promoter
  • Rob ChessDirector
Offering amount
$37M
Amount sold
$37M
First sale
May 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news